Publication | Closed Access

Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases

Surgical OncologyGastrointestinal OncologyMedicineCancer ManagementGastroenterologyPhase Ii StudySurgeryGastric CancerCancer TreatmentSystemic CapecitabineOncologyRadiation Oncology